Icagen, Inc. — Form D/A
Icagen, Inc. of DURHAM, NC, a company, filed a Form D amendment with the SEC on 2015-01-15. The offering totals $8.9M, of which $8.9M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-01-15
- Form: D/A
- Accession: 0001213900-15-000331
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $8.9M
- Amount sold: $8.9M
- Minimum investment: $10K
- Investors: 162
- Date of first sale: 2014-12-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-230172
Issuer
- Name: Icagen, Inc.
- CIK: 0001518520
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 4222 EMPEROR BLVD., SUITE 350, DURHAM, NC, 27703
- Phone: 919-941-5206
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Benjamin Warner | Executive Officer | Durham, NC |
| Vincent Palmieri | Director | Larchmont, NY |
| MICHAEL TAGLICH | Director | SAN RAMON, CA |
| Richard Cunningham | Executive Officer | Lakeway, TX |
| Mark Korb | Executive Officer | Sherman Oaks, CA |
| Timothy Tyson | Director | Oro Valley, AZ |
| Douglas Krafte | Director | Oro Valley, AZ |
| Douglas Krafte | Executive Officer | Oro Valley, AZ |
| Edward Roffman | Director | Durham, NC |
| Clive Kabatznik | Director | Durham, NC |
| Benjamin Warner | Director | Durham, NC |
| Jeremiel Zimmerman | Director | Los Alamos, NM |
Other filings by this issuer (10)
More